<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32388062</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5883</ISSN><JournalIssue CitedMedium="Internet"><Volume>414</Volume><PubDate><Year>2020</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of the neurological sciences</Title><ISOAbbreviation>J Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>The increase in CSF total protein and immunoglobulins in Chinese patients with sporadic amyotrophic lateral sclerosis: A retrospective study.</ArticleTitle><Pagination><StartPage>116840</StartPage><MedlinePgn>116840</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jns.2020.116840</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-510X(20)30176-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this study was to evaluate total protein (TP) in the cerebrospinal fluid (CSF) and immunoglobulins in the serum and CSF in patients with sporadic amyotrophic lateral sclerosis (sALS). We also assessed the correlations of these variables with sALS progression and severity and estimated their roles in predicting prognosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively collected data on CSF TP and immunoglobulins in the CSF and serum, including immunoglobulin G, immunoglobulin A and immunoglobulin M, from 326 sALS patients. The relationships between these variables and clinical features, including sex, age, disease duration, site of onset, respiratory function and survival time, were analysed by Wilcoxon's nonparametric tests. Kaplan-Meier and Cox proportional hazards models were used to explore whether levels of TP and immunoglobulins in the CSF were independently correlated with the survival time of patients with ALS.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The CSF TP was elevated in 55% of the patients. The median CSF TP was 417.7 (349.4-539.5) mg/L, and 6 patients (2%) had a CSF TP level greater than 1000&#xa0;mg/L. The CSF TP levels were significantly higher in male patients than in female patients (p&lt;.001). In females, the CSF TP had positive associations with onset age (rho =0.196, p&#xa0;=&#xa0;.021) and disease progression rate (DPR) (rho =0.230, p&#xa0;=&#xa0;.035) but negative associations with disease duration (rho&#xa0;=&#xa0;-0.204, p&#xa0;=&#xa0;.016) and revised ALS functional rating scale (ALSFRS-R) (rho&#xa0;=&#xa0;-0.288, p&#xa0;=&#xa0;.008). The ALSFRS-R scores of male patients were negatively correlated with the s-IgM levels (rho&#xa0;=&#xa0;-0.562, p&#xa0;=&#xa0;.005). Onset age was negatively associated with the s-IgM levels (rho&#xa0;=&#xa0;-0.534, p&#xa0;=&#xa0;.005) in females. Kaplan-Meier survival analyses showed that no correlations were found between survival time and the levels of TP and immunoglobulins in the CSF.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Elevated levels of TP and immunoglobulins in the CSF suggest impaired blood-brain barrier (BBB) function and immune responses in the CNS of ALS patients. Higher CSF TP levels were associated with later onset age, a shorter disease duration and worse disease severity in females. The changes in the levels of CSF TP and s-IgM might indicate the severity of the disease in some ALS patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China; College of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongfen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yanran</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Qionghua</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China; College of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zhengqing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China; College of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xusheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China; College of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China. Electronic address: lewish301@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Neurol Sci</MedlineTA><NlmUniqueID>0375403</NlmUniqueID><ISSNLinking>0022-510X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007136">Immunoglobulins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007136" MajorTopicYN="N">Immunoglobulins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">Immunoglobulin</Keyword><Keyword MajorTopicYN="N">Survival</Keyword><Keyword MajorTopicYN="N">Total protein</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32388062</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2020.116840</ArticleId><ArticleId IdType="pii">S0022-510X(20)30176-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>